This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Nabendu Saha: Innovator in Pharmaceutical Chemistry
Introduction
Nabendu Saha is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical health issues.
Latest Patents
Nabendu Saha holds a patent for a novel compound described as 2-Amino-2-[8-(dimethyl carbamoyl)-8-aza-bicyclo[3.2.1]oct-3-yl]-exo-ethanoyl derivatives. This invention includes their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts. The compound is recognized for its potential as a Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor, which is particularly useful in the treatment and prevention of Type II diabetes and related complications.
Career Highlights
Nabendu Saha is currently employed at Lupin, Inc., a prominent pharmaceutical company. His work focuses on innovative solutions that address significant health challenges.
Collaborations
He has collaborated with notable colleagues, including Rajender Kumar Kamboj and Prathap Sreedharan Nair, to advance research and development in the pharmaceutical sector.
Conclusion
Nabendu Saha's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in treatments for diabetes and other health conditions.